How long does a Wegovy approval last with FEP Blue?

Heart Disease Risk Reduction — Applies to Federal Employee Program plans. Initial approval: 6 months. Renewal: every 12 months.

What does FEP Blue require to renew Wegovy?

Heart Disease Risk Reduction — Applies to Federal Employee Program plans. Patient must have lost at least 5% of baseline body weight OR maintained initial 5% weight loss. Comprehensive weight management program participation required. CV indication is covered under the weight management pathway with established CVD as a qualifying comorbidity (BMI ≥ 27 + established CVD).

How current is this information?

The oldest review date among the policies on this page is June 5, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

FEP Blue coverage for Wegovy (Heart Disease Risk

Does FEP Blue cover Wegovy for Heart Disease Risk Reduction?

Yes. FEP Blue covers Wegovy for heart disease risk reduction with prior authorization if your BMI is 27 or higher. Other policy requirements and your plan's benefits also apply.

Policy document

Fep Criteria Wegovy

FEP Blue · PA policy · Federal Employee Program

Effective February 13, 2026. Verified June 5, 2026.

View PDF Download Original insurer source

Federal Employee Program: Covered with requirements. See the qualification pathways below.

Earliest policy review June 5, 2026. How we verify · Check your exact plan

Full requirements: Wegovy for Heart Disease Risk Reduction (1 plan type)

Applies to Federal Employee Program plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

CV risk reduction — injection or tablets (adults with established CVD and overweight/obesity)

All of:

Age 18 or older
Established cardiovascular disease (congenital heart disease, cerebrovascular disease, PAD, coronary heart disease, ACS, MI, unstable angina, coronary or other arterial revascularization, or prior PCI/CABG)
BMI ≥ 27 kg/m2
Participating in a comprehensive weight management program (e.g., Teladoc or another weight loss program)
No dual therapy with another GLP-1 receptor agonist
No dual therapy with another PA-required weight loss medication

Documentation to bring

Documentation of established cardiovascular disease (qualifying event or condition)
Documentation of BMI ≥ 27 kg/m2
Documentation of participation in a comprehensive weight management program
Confirmation of no concurrent GLP-1 receptor agonist therapy
Confirmation of no concurrent PA-required weight loss medication

Quantity limits

all injection strengths — 12 single-dose pens per 84 days (84-day)
tablet — 90 tablets per 90 days (84-day)

Approval and renewal

Initial approval: 6 months
Renewal: every 12 months
Renewal: Patient must have lost at least 5% of baseline body weight OR maintained initial 5% weight loss. Comprehensive weight management program participation required. CV indication is covered under the weight management pathway with established CVD as a qualifying comorbidity (BMI ≥ 27 + established CVD).

Not covered when

Dual therapy with another GLP-1 receptor agonist
Dual therapy with another PA-required weight loss medication
Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [boxed warning contraindication]

Policy note: The policy does not have a standalone CV risk reduction section; this indication is covered under the weight management criteria with established CVD as a qualifying comorbidity for patients with BMI ≥ 27 kg/m2. The FDA-approved CV risk reduction indication (for adults with established CVD and obesity or overweight) is explicitly referenced in the regulatory status section for both injection and tablets. diabetes is not excluded for this pathway.

Policy effective February 13, 2026 · verified June 5, 2026 · source: Fep Criteria Wegovy · View policy document (PDF)

Open on its own page →

Questions people ask

Does FEP Blue cover Wegovy?: Yes. FEP Blue covers Wegovy for heart disease risk reduction with prior authorization if your BMI is 27 or higher. Other policy requirements and your plan's benefits also apply.
How long does a Wegovy approval last with FEP Blue?: Heart Disease Risk Reduction — Applies to Federal Employee Program plans. Initial approval: 6 months. Renewal: every 12 months.
What does FEP Blue require to renew Wegovy?: Heart Disease Risk Reduction — Applies to Federal Employee Program plans. Patient must have lost at least 5% of baseline body weight OR maintained initial 5% weight loss. Comprehensive weight management program participation required. CV indication is covered under the weight management pathway with established CVD as a qualifying comorbidity (BMI ≥ 27 + established CVD).
How current is this information?: The oldest review date among the policies on this page is June 5, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Summary of FEP Blue's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.